Which postcoital contraceptive?

doi:10.1136/bmj.321.7262.664

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Christopher Cates, general practitioner

Watford

A few weeks ago my senior partner presented the results of a paper published in the Lancet1 comparing the standard Yuzpe method for postcoital contraception (combined oestrogen and progesterone) with two doses of progesterone only (levonorgestrel 0.75 mg). Until now the latter has required women to take large numbers of tablets, but a formulation in two single tablets has become available in the United Kingdom (Levonelle-2). A large number of women requesting emergency contraception were studied, 1998 enrolled, and the outcomes were known for 1955 …